![Table 2 from FIGO staging system for endometrial cancer: added benefits of MR imaging. | Semantic Scholar Table 2 from FIGO staging system for endometrial cancer: added benefits of MR imaging. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ed9e83cd3039e4c7fbb81ebc70ffc608cfa34b3a/5-Table2-1.png)
Table 2 from FIGO staging system for endometrial cancer: added benefits of MR imaging. | Semantic Scholar
![FDG PET/CT assessment to validate and determine prognostic value of new FIGO staging system 2018 in patients with squamous cell carcinoma of the uterine cervix. | Journal of Nuclear Medicine FDG PET/CT assessment to validate and determine prognostic value of new FIGO staging system 2018 in patients with squamous cell carcinoma of the uterine cervix. | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/supplement_1/351/F1.large.jpg)
FDG PET/CT assessment to validate and determine prognostic value of new FIGO staging system 2018 in patients with squamous cell carcinoma of the uterine cervix. | Journal of Nuclear Medicine
![Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial - The Lancet Oncology Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d1f68703-74b8-4712-ab0a-a260f476e76a/gr1.gif)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial - The Lancet Oncology
![From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009082582101324X-ga1.jpg)
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect
![The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas - ScienceDirect The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147027219302260-gr1.jpg)
The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas - ScienceDirect
![The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging | RadioGraphics The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.326125519/asset/images/medium/125519t06.gif)
The Revised FIGO Staging System for Uterine Malignancies: Implications for MR Imaging | RadioGraphics
![PDF] Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging | Semantic Scholar PDF] Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/29e21e22d9ac379f83e40cd520d75d9e9b4c0a92/3-Table2-1.png)
PDF] Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging | Semantic Scholar
![Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification](https://pub.mdpi-res.com/cancers/cancers-13-05848/article_deploy/html/images/cancers-13-05848-g001.png?1637567362)
Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
![Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 2 (2018) Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 2 (2018)](https://jnccn.org/view/journals/jnccn/16/2/0201tbl01.jpeg)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 2 (2018)
![Table 4 from The revised FIGO staging system for uterine malignancies: implications for MR imaging. | Semantic Scholar Table 4 from The revised FIGO staging system for uterine malignancies: implications for MR imaging. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d8a8f8411b116ba21122cef9f76f985ac21c278d/7-Table4-1.png)